Search

everythinglearnresearchcommunity

for

Search:↓

Lower hair zinc and copper levels found in Turkish males with hair loss; higher BMI linked to less hair zinc.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Hair can be used to measure cancer-related chemicals noninvasively.

Dutasteride and finasteride affect different cell types differently.

A woman with a rare adrenal tumor and hormonal disorder had improved testosterone levels after surgery, but her menstrual irregularities continued.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Glioblastoma cells can make androgens, which might help the tumor grow.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

People with hair loss often have lower levels of zinc and copper in their blood.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Copper deficiency is linked to post-COVID-19 hair loss in women.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.